Projects per year
Personal profile
Education
- 2010 Ph.D., Graduate Institute of Medicine, Kaohsiung Medical University, Taiwan
- 2005 MS, Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Taiwan
- 2004 Bachelor, Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Taiwan
Experience
- 2022- Professor, Graduate Institute of Pharmacognosy, Taipei Medical University, Taiwan
- 2017-2022 Associate Professor, Graduate Institute of Pharmacognosy, Taipei Medical University, Taiwan
- 2016-2017 Assistant Professor, Ph.D. Program in Biotechnology Research and Development, Taipei Medical University
- 2015-2017 Assistant Professor, Ph.D. Program for Translational Medicine, Taipei Medical University
- 2012-2017 Assistant Professor, Graduate Institute of Pharmacognosy, Taipei Medical University, Taiwan
- 2010-2011 Adjunct Assistant Professor, Department and Graduate of Aquaculture, National Kaohsiung Marine University, Taiwan
Awards
- 2021 科技部吳大猷先生紀念獎_藥學領域
-
2020 國家新創獎_新創精進
- 2019 國家新創獎_學研新創
- 2012 戰國策創業競賽 (特優獎)
- 2008 National Innovation Award (The First Prize)
Fingerprint
Dive into the research topics where Kuo-Hsiang Chuang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of Humanized Antagonistic Bace-2 Antibody and Its Derivative Pd-L1 Fusion Protein Drug as a Novel Islet-Protective Strategy for Comprehensive Application in the Treatment of Type 1 and Type 2 Diabetes
Chuang, K.-H. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Development of Humanized Antagonistic Bace-2 Antibody and Its Derivative Pd-L1 Fusion Protein Drug as a Novel Islet-Protective Strategy for Comprehensive Application in the Treatment of Type 1 and Type 2 Diabetes
Chuang, K.-H. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Development of Humanized Antagonistic Bace-2 Antibody and Its Derivative Pd-L1 Fusion Protein Drug as a Novel Islet-Protective Strategy for Comprehensive Application in the Treatment of Type 1 and Type 2 Diabetes
Chuang, K.-H. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Development of Antagonistic Bace-2 Antibodies to Improve Type 2 Diabetes by Inducing Pancreatic Beta-Cells Proliferation( III )
Chuang, K.-H. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Development of Antagonistic Bace-2 Antibodies to Improve Type 2 Diabetes by Inducing Pancreatic Beta-Cells Proliferation( II )
Chuang, K.-H. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safety
Liao, T. Y., Liu, Y. L., Chen, C. Y., Wu, B. T., Liu, E. S., Hong, S. T., Huang, B. C., Cheng, Y. A., Chen, M., Chuang, K. H., Lin, W. W., Chuang, C. H., Chen, F. M., Ho, K. W. & Cheng, T. L., May 2025, In: International Journal of Biological Macromolecules. 305, 141003.Research output: Contribution to journal › Article › peer-review
-
Melatonin reverses bisphenol A-induced toxicity in granulosa cells: Restoration of FSHR and connexin 43 expression
Lin, T. C., Wang, K. H., Chuang, K. H., Kao, A. P. & Kuo, T. C., 2025, (Accepted/In press) In: Taiwanese Journal of Obstetrics and Gynecology. 64, 3, p. 469-476 8 p.Research output: Contribution to journal › Article › peer-review
-
Nonshrinkable Thermosensitive Hydrogels Combined with Bispecific Anti-PSMA/CD3 T-Cell Engager for Effective Against Tumors in Mice Model
Wei, P. S., Chou, P. Y., Hsu, H. Y., Chen, M., Chen, Y. J., Tsai, T. H., Wen, B. Y., Sheu, M. T., Chuang, K. H. & Lin, H. L., 2025, In: International Journal of Nanomedicine. 20, p. 3083-3111 29 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Celecoxib attenuates interleukin 33-induced expression of vascular cell adhesion molecule-1 in human ovarian endometriotic stromal cells
Lin, T. C., Wang, K. H., Chuang, K. H., Kao, A. P. & Kuo, T. C., Mar 2024, In: Taiwanese Journal of Obstetrics and Gynecology. 63, 2, p. 178-185 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
The angiogenic role of the alpha 9-nicotinic acetylcholine receptor in triple-negative breast cancers
Ochirbat, S., Kan, T. C., Hsu, C. C., Huang, T. H., Chuang, K. H., Chen, M., Cheng, C. C., Chang, C. C., Rahayu, S. & Chang, J., 2024, (Accepted/In press) In: Angiogenesis. 27, 4, p. 827-843 17 p.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus)
Datasets
-
Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer
Cheng, Y.-A. (Creator), Wu, T.-H. (Contributor), Wang, Y.-M. (Contributor), Cheng, T.-L. (Creator), Chen, I.-J. (Creator), Lu, Y.-C. (Contributor), Chuang, K.-H. (Contributor), Wang, C.-K. (Contributor), Chen, C.-Y. (Creator), Lin, R.-A. (Creator), Chen, H.-J. (Creator), Liao, T.-Y. (Contributor), Liu, E.-S. (Contributor) & Chen, F.-M. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5105096.v1, https://springernature.figshare.com/collections/Humanized_bispecific_antibody_mPEG_HER2_rapidly_confers_PEGylated_nanoparticles_tumor_specificity_for_multimodality_imaging_in_breast_cancer/5105096/1
Dataset
-
Additional file 1 of A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies
Wang, Y.-T. (Creator), Huang, B.-C. (Creator), Hsieh, Y.-C. (Creator), Ho, K.-W. (Creator), Cheng, T.-L. (Creator), Wang, J.-Y. (Creator), Liu, H.-J. (Creator), Tsai, H.-L. (Creator), Liao, J.-M. (Creator), Liu, Y.-L. (Creator), Hong, S.-T. (Creator), Chen, I.-J. (Creator), Su, Y.-C. (Creator) & Chuang, K.-H. (Creator), Figshare, 2022
DOI: 10.6084/m9.figshare.19101789.v1, https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_A_universal_in_silico_V_D_J_recombination_strategy_for_developing_humanized_monoclonal_antibodies/19101789/1
Dataset
-
Bispecific antibodies (anti-mPEG/anti-HER2) for active tumor targeting of docetaxel (DTX)-loaded mPEGylated nanocarriers to enhance the chemotherapeutic efficacy of HER2-overexpressing tumors
Su, C.-Y. (Contributor), Chen, M. (Contributor), Chen, L.-C. (Contributor), Ho, Y.-S. (Contributor), Ho, H.-O. (Contributor), Lin, S.-Y. (Contributor), Chuang, K.-H. (Contributor) & Sheu, M.-T. (Contributor), Unknown Publisher, May 2 2018
DOI: 10.6084/m9.figshare.6213620.v1, https://tandf.figshare.com/articles/Bispecific_antibodies_anti-mPEG_anti-HER2_for_active_tumor_targeting_of_docetaxel_DTX_-loaded_mPEGylated_nanocarriers_to_enhance_the_chemotherapeutic_efficacy_of_HER2-overexpressing_tumors/6213620/1
Dataset
-
Additional file 1 of Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer
Liu, E.-S. (Contributor), Wang, C.-K. (Contributor), Chuang, K.-H. (Contributor), Chen, F.-M. (Creator), Wu, T.-H. (Contributor), Chen, C.-Y. (Creator), Chen, I.-J. (Creator), Lin, R.-A. (Creator), Wang, Y.-M. (Contributor), Lu, Y.-C. (Contributor), Liao, T.-Y. (Contributor), Chen, H.-J. (Creator), Cheng, T.-L. (Creator) & Cheng, Y.-A. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.12885938.v1, https://doi.org/10.6084%2Fm9.figshare.12885938.v1
Dataset
-
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies
Hsieh, Y.-C. (Creator), Liao, J.-M. (Creator), Chuang, K.-H. (Creator), Ho, K.-W. (Creator), Hong, S.-T. (Creator), Liu, H.-J. (Creator), Huang, B.-C. (Creator), Chen, I.-J. (Creator), Liu, Y.-L. (Creator), Wang, J.-Y. (Creator), Tsai, H.-L. (Creator), Su, Y.-C. (Creator), Wang, Y.-T. (Creator) & Cheng, T.-L. (Creator), Figshare, 2022
DOI: 10.6084/m9.figshare.c.5819661.v1, https://springernature.figshare.com/collections/A_universal_in_silico_V_D_J_recombination_strategy_for_developing_humanized_monoclonal_antibodies/5819661/1
Dataset